Day: June 1, 2022

Vor Bio to Participate in Upcoming Investor Conferences

Written by Customer Service on June 1, 2022. Posted in Public Companies.

CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences: Jefferies Healthcare ConferencePresentation date: Wednesday, June 8, 2022Presentation time: 2:30 PM ETLocation: Marriott Marquis, New York, NY Goldman Sachs 43rd Annual Global Healthcare Conference Dates: June 13-16, 20221×1 meetings onlyLocation: Terranea Resort, Ranch Palos Verdes, CA JMP Securities Life Sciences ConferenceFireside Chat date: Thursday, June 16, 2022Presentation time: 11:00 AM ETLocation: The Lotte New York Palace Hotel, New York, NY Stifel’s 2022 Virtual Cell Therapy SummitDates: June 29-30, 2022 Live webcasts and archived replays of key presentations will be available on the Company’s...

Ventyx Biosciences to Participate in the Jefferies Healthcare Conference

Written by Customer Service on June 1, 2022. Posted in Public Companies.

ENCINITAS, Calif., June 01, 2022 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced that Raju Mohan, Chief Executive Officer of Ventyx, will provide a company overview during a fireside chat at the Jefferies Healthcare Conference being held June 8-10, 2022.Event: Jefferies Healthcare ConferenceLocation: New York, NYDate: Wednesday, June 8, 2022Time: 4:00-4:25 PM ETMembers of the Ventyx management team will also host investor meetings during the conference. A webcast of the fireside chat will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com. A webcast replay will also be available on...

Atos, UCL and Arm team up to offer wider cloud computing possibilities for life sciences applications

Written by Customer Service on June 1, 2022. Posted in Public Companies.

Atos, UCL and Arm team up to offer wider cloud computing possibilities for life sciences applications Paris, France – June 1st, 2022 – Atos and UCL today announce having successfully run the virus sequencing tool, Viridian, which is used to detect mutation of the SARS-Cov-2 strain of the coronavirus, using an Arm®-based Ampere® Altra® processor in a cloud native environment with Atos’ integration expertise. This proof of concept (PoC) was coordinated by Atos’ Life Sciences Center of Excellence which aims to foster a culture of exploration, discovery and co-creation to harness the power of digital technologies in order to advance precision health and accelerate the discovery and development of drugs. With data growing exponentially and becoming more difficult to process for life sciences applications, data, scientists rely on high-performance...

Form 8.3 – [LXi REIT plc – 31 05 2022] – (CGWL)

Written by Customer Service on June 1, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree LXI REIT PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Vision Hydrogen Acquires Advanced Renewable Fuels Development Project

Written by Customer Service on June 1, 2022. Posted in Mergers And Acquisitions.

JERSEY CITY, N.J., June 01, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Vision Hydrogen Corporation (OTCQB: VIHD) (the “Company”) announces that it has acquired a 100% interest in a 14 Ha port development project (the “Project”) for the storage and distribution of low carbon and renewable fuels, including hydrogen carriers such as ammonia, methanol and liquid organics, strategically located in Vlissingen (Flushing) at the mouth of the Westerschelde estuary in the Netherlands. The Project is well positioned to be the first terminal in Europe with a core focus on the storage of low carbon and renewable fuels (including hydrogen carriers from which clean hydrogen may be produced) for European markets and off-takers providing carbon abatement. About Evolution TerminalsEvolution Terminals BV (“EVO”) benefits from a long-lease agreement...

Form 8.3 – [Ideagen plc – 31 05 2022] – (CGWL)

Written by Customer Service on June 1, 2022. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree IDEAGEN PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDEAGEN PLC AS AN ASSOCIATE OF THE...

Completion of Pharma Intelligence Acquisition by Warburg Pincus From Informa PLC and Appointment of Executive Chair

Written by Customer Service on June 1, 2022. Posted in Mergers And Acquisitions.

LONDON and NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) — Pharma Intelligence, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, announces that Warburg Pincus, a leading global growth investor, has completed its acquisition of the business from Informa PLC (LSE:INF.L), the international Academic Markets, B2B Markets and Digital Services Group. The acquisition includes Informa’s full portfolio of specialist brands which includes the Citeline suite of products (Trialtrove, Sitetrove, Pharmaprojects) as well as Biomedtracker, Clinerion, Datamonitor Healthcare, Pink Sheet, Scrip, Skipta, and TrialScope. Pharma Intelligence will now enter its next phase of growth under new ownership. As announced on February 10, Mubadala Investment Company, the Abu Dhabi based...

ReliaQuest to Acquire Digital Shadows

Written by Customer Service on June 1, 2022. Posted in Mergers And Acquisitions.

Combined company creates world-class security operations platform to offer customers unmatched visibility and detection to defend against threats TAMPA, Fla., June 01, 2022 (GLOBE NEWSWIRE) — ReliaQuest, a force multiplier of security operations, today announced that it has entered into an agreement to acquire Digital Shadows, a company that delivers threat intelligence for security teams, for $160 million. The acquisition combines ReliaQuest’s ability to extend detection and response across cloud, network, and endpoint environments with Digital Shadows’ digital risk and threat intelligence technology. This gives security operations teams the ability to detect and respond to threats with real-time internal and external visibility. “Combining the internal visibility provided by ReliaQuest with the external threat intelligence...

American Lithium Adds Further Concessions Close to Its Existing Projects in Southern Peru

Written by Customer Service on June 1, 2022. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, June 01, 2022 (GLOBE NEWSWIRE) — American Lithium Corp. (“American Lithium” or the Company”) (TSX-V: LI, OTCQB: LIACF, Frankfurt: 5LA1) is pleased to confirm that it has signed an agreement to acquire additional concessions in Southern Peru. In addition, it has entered into agreements relating to public relations and marketing activities. Acquisition of Concessions in Southern Peru The Company, through its Peruvian subsidiary, Macusani Yellowcake S.A.C., has entered into a mining rights transfer agreement (the “Transfer Agreement”) with an arms-length third-party, pursuant to which it will acquire the rights to a series of mining concessions (the “Concessions”) covering approximately 14,243 hectares in Southern Peru. The Concessions are highly prospective and will further broaden the Company’s existing...

IBI Group Enhances Mobility-Based Solutions with Acquisition of HotSpot

Written by Customer Service on June 1, 2022. Posted in Mergers And Acquisitions.

– Complementary mobility solution strengthens IBI’s SaaS portfolio and broadens recurring revenue – TORONTO, June 01, 2022 (GLOBE NEWSWIRE) — Global design and technology firm, IBI Group Inc. (TSX: IBG) (“IBI” or the “Company”), announced today that it has acquired mobility solutions provider, HotSpot (the “Acquisition”). Founded in New Brunswick in 2013, HotSpot began addressing parking issues through technology and has since developed into a suite of integrated mobility solutions. Currently, the platform is in use across Canada and parts of the U.S., with more than 80 municipalities, cities and universities, and 460,000 mobile application users leveraging the platform’s mobility solutions. HotSpot’s suite of solutions will complement and bolster IBI’s traffic and transportation practice and its extensive offering...

Day: June 1, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice